FDA declines approval bid for Neffy, a needle-free EpiPen alternative
ASR Pharma said it was surprised and "deeply disappointed" by the FDA request for more trial data on its Neffy nasal spray for severe allergic reactions.
Watch CBS News
ASR Pharma said it was surprised and "deeply disappointed" by the FDA request for more trial data on its Neffy nasal spray for severe allergic reactions.
Generic drugmaker Sandoz announced plans Thursday to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.
The U.S. is experiencing an EpiPen shortage and parents are scrambling because some schools won't let kids with allergies in the classroom if they don't have one.
The Food and Drug Administration on Thursday cleared Teva Pharmaceutical Industries to start selling generic versions EpiPen and EpiPen Jr., years after the Israeli drugmaker requested it.
Parents of children with severe allergies are scrambling to find epinephrine injectors, potentially life-saving medication, as the start of school draws near.
An Illinois man has a local pharmacist to thank for thinking fast when he ran into her store experiencing an allergic reaction.
CVS is now selling a rival generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated because of its soaring cost.
Lawmakers are venting outrage over high prescription drug costs, but if Congress is looking for culprits, it might want to look in the mirror.
Mylan CEO Heather Bresch infuriated lawmakers as she tried to explain steep cost increases of her company's life-saving EpiPens.
The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers.
Following the public outcry over steep increases in the price for an emergency allergy treatment, Hillary Clinton is rolling out a plan on Friday, pledging to better protect patients from such costs.
Mylan says it will make available a generic version of its EpiPen, as criticism continued to mount over the price of its injectable medicine.
Saying that she is "disappointed, saddened and deeply concerned" by the price hike of the EpiPen, actress Sarah Jessica Parker has cut ties with the company that makes the emergency allergy treatment.
Mylan, now in the crosshairs over severe price hikes for its EpiPen, says it will expand programs that lower out-of-pocket costs by as much as half.
For someone with an allergy, an EpiPen can mean the difference between life and death. The price of the indispensable injectable drug has soared in recent years.
